Phase 2 N=52 Ibudilast and Withdrawal-Related Dysphoria
Alcohol Use Disorder
Primary: Negative Affect — 2.91; 2.47 units — p=.62
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=986 Understanding Perceived Access and Receipt of Gender-affirming Treatments Among Transgender Veterans
Gender Dysphoria
Primary: Receipt of Gender Affirming Treatment — 769; 687; 292; 468 Participants
N/A N=186 Sibling-Support for Adolescent Girls (SSAGE)
Anxiety · Depression · Mental Illness
Primary: Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 Level 1 Cross-Cutting Symptom — 44; 42; 24; 28 Participants
N/A N=75 Family Based Contingency Management for Adolescent Alcohol Abuse
Alcohol Abuse
Primary: Alcohol Abstinence — 2.9; 2.6 Samples — p=0.66
N/A N=39 Transcranial Magnetic Stimulation for Adolescent Depression
Major Depressive Disorder
Primary: Hamilton Depression Rating Scale — 9.38 score on a scale
N/A N=121 Promoting Viral Suppression Among Transgender Women Living With HIV in Santo Domingo
HIV
Primary: Number of Participants With Viral Suppression (HIV), 6 Months — 31; 33 Participants — p=0.489
Phase 3 N=81 Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE)
Eosinophilic Esophagitis
Primary: Percentage of Participants Achieving Peak Esophageal Intraepithelial Eosinophil Count of ≤6 Eosinophils Per High-power Field (Eos/Hpf) in All Three Regions at Week 24…
N/A N=660 Puerto Rico Cuidalos Parent-adolescent Program
HIV/AIDS and Infections · Sexually Transmitted Diseases · Pregnancy Prevention
Primary: Change From Baseline to 3 Months in Parent - Adolescent Sexual Risk Communication (Parental Perspective) — 0.54; 0.28 units on a scale
Phase 2 N=134 Combined Pharmaco/Behavior Therapy in Adolescent Smokers
Nicotine Dependence · Nicotine Use Disorder
Primary: Biologically-verified 7-day Point Prevalence Smoking Abstinence — 10; 3; 3; 3 participants — p=0.07
N/A N=2,006 Evaluation Of "Coaching Boys Into Men" (CBIM) Program
Violence · Abuse
Primary: Change From Baseline to 3 Months Using the Recognition of Abusive Behavior Scale — 3.38; 3.37 mean scores
Phase 4 N=35 Counseling Among Gender Diverse Adolescents Who Use Depot Medroxyprogesterone
Gender Dysphoria, Adolescent
Primary: Number of Participants Satisfied With Self-Administered DMPA at Initiation — 17 Participants
N/A N=20 Sexual and Gender Minority Emerging Adults Eliciting Narratives
Mental Health Wellness 1 · Sexual Orientation · Gender Identity
Primary: Patient Health Questionnaire (PHQ-9) — 14.29; 11.50 score on a scale
Phase 4 N=50 The Effect of Pectoral Blocks on Perioperative Pain in Gender Affirmation Top Surgery
Gender Dysphoria · Opioid Use · Pain, Postoperative
Primary: Comparison of Post Operative Pain Scores — 3.0; 3.6 score on a scale
N/A N=151 Economic and Social Empowerment To Increase Upwards Mobility Among Women
Sexually Transmitted Infections · Human Immunodeficiency Virus
Primary: Number of Participants With Decreased Economic Vulnerability — 51; 37 Participants
Phase 3 N=3,900 A Study of Heterologous Vaccine Regimen of Adenovirus Serotype 26 Mosaic4 Human Immunodeficiency Virus(Ad26.Mos4.HIV), Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and Transgender Individuals Who Have Sex With Cis-gender Men and/or Transgender Individuals
Healthy
Primary: Number of Participants With Confirmed Human Immunodeficiency Virus (HIV)-1 Infections Diagnosed Between the Month 7 and Month 24 Visits (Per-protocol [PP] Set) — 65; 58…